Associations between complete remission and 2- to 3-year survival following 7 + 3 induction for acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Associations between complete remission and 2- to 3-year survival following 7 + 3 induction for acute myeloid leukemia

Published:2021-03-10 Issue:8 Volume:62 Page:1967-1972
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Othus Megan¹²,Garcia-Manero Guillermo³,Godwin John⁴,Weick James⁵,Stirewalt Derek²,Appelbaum Frederick²,Erba Harry⁶,Estey Elihu²

Affiliation:

1. SWOG Statistical Center, Seattle, WA, USA

2. Fred Hutchinson Cancer Research Center, Seattle, WA, USA

3. MD Anderson Cancer Center, Houston, TX, USA

4. Providence Onc/Hem Care Clinic, Portland, OR, USA

5. VA Medical Center, North Palm Beach, FL, USA

6. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1885663

Reference19 articles.

1. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

2. A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

3. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

4. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

5. Garcia-Manero G, Othus M, Pagel JM, et al. SWOG S1203: a randomized phase III study of standard cytarabine plus daunorubicin (7 + 3) therapy versus idarubicin with high dose cytarabine (IA) with or without vorinostat (IA + V) in younger patients with previously untreated acute myeloid leukemia (AML). Blood. 2016;128(22):901.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients;Journal of Clinical Laboratory Analysis;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3